CoChat

Structure of HIV-1 Reverse Transcriptase with the Inhibitor β-Thujaplicinol Bound at the RNase H Active Site

Open access
Himmel, Daniel M., Maegley, Karen A., Pauly, Tom A., Bauman, Joseph D., Das, Kalyan, Dharia, Chhaya, Clark, Arthur D., Ryan, Kevin, Hickey, Michael J., Love, Robert A., Hughes, Stephen H., Bergqvist, Simon, Arnold, Eddy · 2009 · Structure
Cited by 140

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Summary Novel inhibitors are needed to counteract the rapid emergence of drug-resistant HIV variants. HIV-1 reverse transcriptase (RT) has both DNA polymerase and RNase H (RNH) enzymatic activities, but approved drugs that inhibit RT target the polymerase. Inhibitors that act against new targets, like RNH, would be effective against all of the current drug-resistant variants. Here, we present 2.80 Å and 2.04 Å resolution crystal structures of an RNH inhibitor, β-thujaplicinol, bound at the RNH active site of both HIV-1 RT and an isolated RNH domain. β-thujaplicinol chelates two divalent metal ions at the RNH active site. We provide biochemical evidence that β-thujaplicinol is a slow-binding RNH inhibitor with non-competitive kinetics and suggest that it forms a tropylium ion that interacts favorably with RT and the RNA:DNA substrate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.str.2009.09.016

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 42

  1. Bauman, 2008, Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design, Nucleic Acids Res., 36, 5083, 10.1093/nar/gkn464 · DOI · Paper page
  2. Beilhartz, 2009, HIV-1 reverse transcriptase can simultaneously engage its DNA/RNA substrate at both DNA polymerase and RNase H active sites: implications for RNase H inhibition, J. Mol. Biol., 388, 462, 10.1016/j.jmb.2009.03.025 · DOI · Paper page
  3. Brodsky, 2006, Economical parallel protein expression screening and scale-up in Escherichia coli, J. Struct. Funct. Genomics, 7, 101, 10.1007/s10969-006-9013-0 · doi:10.1007/s10969-006-9013-0
  4. Brünger, 1998, Crystallography and NMR system: a new software suite for macromolecular structure determination, Acta Crystallogr. D Biol. Crystallogr., 54, 905, 10.1107/S0907444998003254 · DOI · Paper page
  5. Budihas, 2005, Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones, Nucleic Acids Res., 33, 1249, 10.1093/nar/gki268 · DOI · Paper page
  6. Clark, 1995, Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors and an antibody fab fragment, Methods Enzymol., 262, 171, 10.1016/0076-6879(95)62017-6 · DOI
  7. Cogan, 1976, Binding affinities of retinol and related compounds to retinol binding proteins, Eur. J. Biochem., 65, 71, 10.1111/j.1432-1033.1976.tb10390.x · DOI · Paper page
  8. Dewar, 1945, Structure of stipitatic acid, Nature, 155, 50, 10.1038/155050b0 · DOI · Paper page
  9. Ding, 1997, Protein-nucleic acid interactions and DNA conformation in a complex of human immunodeficiency virus type 1 reverse transcriptase with a double-stranded DNA template-primer, Biopolymers, 44, 125, 10.1002/(SICI)1097-0282(1997)44:2<125::AID-BIP2>3.0.CO;2-X · DOI
  10. Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
  11. Engh, 1991, Accurate bond and angle parameters for x-ray protein structure refinement, Acta Crystallogr. A, 47, 392, 10.1107/S0108767391001071 · DOI · Paper page
  12. Gardner, 1957, Occurrence of 2,7-dihydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one (7-hydroxy-4-iso-propyltropolone) in Western Red Cedar (Thuja plicata Donn.), Can. J. Chem., 35, 1039, 10.1139/v57-141 · doi:10.1139/v57-141
  13. Garvey, 2008, The Naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral, Antimicrob. Agents Chemother., 52, 901, 10.1128/AAC.01218-07 · DOI
  14. Goedken, 2001, Co-crystal of Escherichia coli RNase HI with Mn2+ ions reveals two divalent metals bound in the active site, J. Biol. Chem., 276, 7266, 10.1074/jbc.M009626200 · DOI · Paper page
  15. Hang, 2004, Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides, Biochem. Biophys. Res. Commun., 317, 321, 10.1016/j.bbrc.2004.03.061 · DOI
  16. Himmel, 2006, HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site, ACS Chem. Biol., 1, 702, 10.1021/cb600303y · DOI · Paper page
  17. Hsiou, 1996, Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: implications of conformational changes for polymerization and inhibition mechanisms, Structure, 4, 853, 10.1016/S0969-2126(96)00091-3 · DOI · Paper page
  18. Huang, 1998, Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance, Science, 282, 1669, 10.1126/science.282.5394.1669 · DOI · Paper page
  19. Jones, 1991, Improved experimental procedures for building protein models in electron-density maps and the location of errors in these models, Acta Crystallogr. A, 47, 110, 10.1107/S0108767390010224 · DOI · Paper page
  20. Katayanagi, 1993, Crystal structure of Escherichia coli Rnase HI in complex with Mg2+ at 2.8 A resolution: proof for a single Mg(2+)-binding site, Proteins, 17, 337, 10.1002/prot.340170402 · DOI · Paper page
  21. Keck, 1998, Activation/attenuation model for RNase H: a one-metal mechanism with second-metal inhibition, J. Biol. Chem., 273, 34128, 10.1074/jbc.273.51.34128 · DOI · Paper page
  22. Kleywegt, 1996, Checking your imagination: applications of the free R value, Structure, 4, 897, 10.1016/S0969-2126(96)00097-4 · DOI · Paper page
  23. Kleywegt, 1994, Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid, Structure, 2, 1241, 10.1016/S0969-2126(94)00125-1 · DOI · Paper page
  24. Klumpp, 2006, Recent progress in the design of small molecule inhibitors of HIV RNase H, Curr. Pharm. Des., 12, 1909, 10.2174/138161206776873653 · DOI · Paper page
  25. Klumpp, 2003, Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors, Nucleic Acids Res., 31, 6852, 10.1093/nar/gkg881 · DOI · Paper page
  26. Kolomnikova, 1967, Advances in the chemistry of the tropylium ion, Russ. Chem. Rev., 36, 735, 10.1070/RC1967v036n10ABEH001768 · doi:10.1070/rc1967v036n10abeh001768
  27. Krishnaswamy, 2005, Exosite-driven substrate specificity and function in coagulation, J. Thromb. Haemost., 3, 54, 10.1111/j.1538-7836.2004.01021.x · DOI
  28. Luzzati, 1952, Traitement statistique des erreurs dans la determination des structure cristallines, Acta Crystallogr., 5, 802, 10.1107/S0365110X52002161 · DOI · Paper page
  29. Murshudov, 1997, Refinement of macromolecular structures by the maximum-likelihood method, Acta Crystallogr. D Biol. Crystallogr., 53, 240, 10.1107/S0907444996012255 · DOI · Paper page
  30. Nowotny, 2007, Structure of Human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription, Mol. Cell, 28, 264, 10.1016/j.molcel.2007.08.015 · DOI · Paper page
  31. Oda, 1991, Binding of metal ions to E. Coli RNase HI observed by 1H-15N heteronuclear 2D NMR, J. Biomol. NMR, 1, 247, 10.1007/BF01875518 · DOI
  32. Parniak, 2003, A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity, Anal. Biochem., 322, 33, 10.1016/j.ab.2003.06.001 · DOI
  33. Pauson, 1955, Tropones and tropolones, Chem. Rev., 55, 9, 10.1021/cr50001a002 · doi:10.1021/cr50001a002
  34. Pietra, 1973, Seven-membered conjugated carbo- and heterocyclic compounds and their homoconjugated analogs and metal complexes: synthesis, biosynthesis, structure, and reactivity, Chem. Rev., 73, 293, 10.1021/cr60284a002 · doi:10.1021/cr60284a002
  35. Read, 2001, Pushing the boundaries of molecular replacement with maximum likelihood, Acta Crystallogr. D Biol. Crystallogr., 57, 1373, 10.1107/S0907444901012471 · DOI · Paper page
  36. Richardson, 2006, Mechanism of Mos1 transposition: insights from structural analysis, EMBO J., 25, 1324, 10.1038/sj.emboj.7601018 · DOI
  37. Sarafianos, 2004, Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases, Curr. Opin. Struct. Biol., 14, 716, 10.1016/j.sbi.2004.10.013 · DOI
  38. Sarafianos, 2001, Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA, EMBO J., 20, 1449, 10.1093/emboj/20.6.1449 · DOI · Paper page
  39. Shaw-Reid, 2003, Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-Yl]-2,4-dioxobutanoic acid, J. Biol. Chem., 278, 2777, 10.1074/jbc.C200621200 · DOI · Paper page
  40. Tisdale, 1991, Mutations within the RNase H domain of HIV-1 RT abolish virus infectivity, J. Gen. Virol., 72, 59, 10.1099/0022-1317-72-1-59 · DOI · Paper page
  41. Wittwer, 2007, Substrate-dependent inhibition kinetics of an active site-directed inhibitor of ADAMTS-4 (Aggrecanase 1), Biochem, 46, 6393, 10.1021/bi7000642 · DOI
  42. Yang, 1990, Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein, Science, 249, 1398, 10.1126/science.2169648 · DOI · Paper page

Cited by

See all 140

Metadata

Authors
Himmel, D. M., Maegley, K. A., Pauly, T. A., Bauman, J. D., Das, K., Dharia, C., Clark, A. D., Ryan, K., Hickey, M. J., Love, R. A., Hughes, S. H., Bergqvist, S., & Arnold, E.
Venue
Structure
Publisher
Elsevier BV
Published
2009-12
Volume
17
Issue
12
Pages
1625-1635
ISSN
0969-2126 (ISSN-L)
OpenAlex
W2063387690
Cited by
140
References
9
FWCI
6.49
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structure of HIV-1 Reverse Transcriptase with the Inhibitor β-Thujaplicinol Bound at the RNase H Active Site. https://app.cochat.ai/papers/10.1016/j.str.2009.09.016
The paper
Himmel, D. M., Maegley, K. A., Pauly, T. A., Bauman, J. D., Das, K., Dharia, C., Clark, A. D., Ryan, K., Hickey, M. J., Love, R. A., Hughes, S. H., Bergqvist, S., & Arnold, E. (2009). Structure of HIV-1 Reverse Transcriptase with the Inhibitor β-Thujaplicinol Bound at the RNase H Active Site. Structure. https://doi.org/10.1016/j.str.2009.09.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.